Delivery Order SPE2DB20D7059-SPE2DB24FPVE5
Award Date 12/6/23
Potential Completion Date 12/7/23
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $61,256 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. This delivery order was placed under Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies for military treatment programs and facilities. The contract has a completion date of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceuticals. The $1,053.72 contract has a completion date of December 21, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceutical products and medical supplies to support DLA programs. No set-aside designation was used for this...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceuticals. The contract has a potential value of $10,197.78 and a performance period through January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order contract is issued under a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,604.80 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The contract has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, operating through its Corporate Office division, is a prime contractor providing a range of pharmaceutical and medical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,107.44 firm fixed price delivery order is for the provision of MENQUADFI VIAL 0.5ML pharmaceutical products. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $142,619.35 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $35,124.00 to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564017415 MENQUADFI VIAL 0.5ML. The contract has a ceiling value of $10,537.20 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to deliver...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The firm fixed price delivery order has a potential value of $2,809.92 and a completion date of December 22, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides a range of pharmaceutical products and medical...
- This federal contract award is for the delivery of 4564556839 MENQUADFI VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $35,124.00 and is a Firm Fixed Price Delivery Order with a completion date of May 10, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug...